Skip to main content
OpenTrials

Clinical trial condition

Pulmonary Arterial Hypertension

Explore clinical trials studying Pulmonary Arterial Hypertension. Study availability and eligibility vary by location and protocol.

354 public trials 45 recruiting studies
Refine in advanced search Browse all conditions

Pulmonary Arterial Hypertension trial results

Completed

Imatinib (QTI571) in Pulmonary Arterial Hypertension

NCT00902174

Conditions
Cardiovascular Diseases, Hypertension, Hypertension, Pulmonary, +4 more
Locations
  • Novartis Investigative Site Birmingham, Alabama, United States
  • Novartis Investigative Site Phoenix, Arizona, United States
  • Novartis Investigative Site Los Angeles, California, United States
  • Novartis Investigative Site San Francisco, California, United States
View all 95 locations
View Trial Details
Completed

Study of Incidence of Respiratory Tract AEs in Patients Treated With Tyvaso® Compared to Other FDA Approved PAH Therapies

NCT01266265

Conditions
Hypertension, Pulmonary, Lung Diseases, Pathologic Processes, +5 more
Locations
  • Cardiovascular Associates, P.C. Birmingham, Alabama, United States
  • The University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of South Alabama Mobile, Alabama, United States
  • Arizona Pulmonary Specialists, LTD Phoenix, Arizona, United States
View all 88 locations
View Trial Details
Completed

Safety Study Extension of Iloprost Power 15 in Pulmonary Arterial Hypertension

NCT00709098

Conditions
Hypertension, Pulmonary, Lung Diseases, Pulmonary Arterial Hypertension, +1 more
Locations
  • UCSD Medical Center La Jolla, California, United States
  • UC Davis Medical Center Sacramento, California, United States
  • Liu Center for Pulmonary Hypertension - LA Biomedical Research Institute at Harbor-UCLA Torrance, California, United States
  • Lung Health & Sleep Enhancement Center, LLC Newark, Delaware, United States
View all 34 locations
View Trial Details
Completed

Study of Macitentan (ACT-064992) on Morbidity and Mortality in Patients With Symptomatic Pulmonary Arterial Hypertension

NCT00660179

Conditions
Hypertension, Pulmonary, Lung Diseases, Pulmonary Arterial Hypertension, +1 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Arizona Pulmonary Specialists Pheonix, Arizona, United States
  • GLVA Healthcare Center Los Angeles, California, United States
  • University of California, San Diego San Diego, California, United States
View all 153 locations
View Trial Details
Completed

Assessmet of Patients With PAH Right Ventricular Volume

NCT01557582

Conditions
Hypertension, Pulmonary, Lung Diseases, Pulmonary Arterial Hypertension, +1 more
Locations
  • University of Chicago Chicago, Illinois, United States
  • Brigham and Women's Hospital Boston, Massachusetts, United States
  • Mayo Clinic Rochester, Minnesota, United States
  • Cleveland Clinic Cleveland, Ohio, United States
View Trial Details
Completed

Tyvaso Dosing and Titration Evaluation: TyTRATE Registry

NCT01799473

Conditions
Hypertension, Pulmonary, Lung Diseases, Pulmonary Arterial Hypertension, +1 more
Locations
  • The Regents of the University of California La Jolla, California, United States
  • UCLA Medical Center Los Angeles, California, United States
  • Southern California Permanente Pasadena, California, United States
  • Central Coast Chest Consultants San Luis Obispo, California, United States
View all 52 locations
View Trial Details
Completed

Safety and Efficacy of Imatinib Mesylate in Patients With Pulmonary Arterial Hypertension

NCT00477269

Conditions
Hypertension, Pulmonary, Lung Diseases, Pulmonary Arterial Hypertension, +1 more
Locations
  • Novartis Investigative Site Los Angeles, California, United States
  • Novartis investigative site Newark, New Jersey, United States
  • Novartis Investigative Site New York, United States
  • Novartis Investigative Site Graz, Austria
View all 13 locations
View Trial Details

Related conditions